This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Bayer Healthcare LLC, Bayer Intellectual Property Gmbh. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: Inventor Noboru Satozawa: Pioneering Cancer Treatment Innovations
Introduction
Noboru Satozawa, an accomplished inventor based in Chiba, Japan, has made significant contributions to the field of cancer research through his innovative patents. With a total of two patents, Satozawa's work focuses on the development of advanced therapeutic and diagnostic tools aimed at targeting and understanding cancer-related disorders.
Latest Patents
Satozawa's most recent patents include "Anti-mesothelin antibodies and uses thereof." This groundbreaking invention presents recombinant antigen-binding regions and antibodies specific for the membrane-anchored, 40 kDa mesothelin polypeptide. Mesothelin is known to be overexpressed in various tumors, including pancreatic and ovarian cancers, mesothelioma, and lung cancer. The antibodies developed from Satozawa’s invention have the potential to treat these cancers and related conditions. Moreover, they can be utilized in the diagnostics sector and to further investigate mesothelin's role in cancer progression. This invention also includes nucleic acid sequences encoding the antibodies, vectors, pharmaceutical compositions, and kits with instructions for use. In addition, he holds a patent related to "Dimeric molecular complexes," which are intended for both diagnostic and therapeutic applications.
Career Highlights
Throughout his career, Noboru Satozawa has worked with prominent organizations, notably Bayer Healthcare LLC and Bayer Intellectual Property GmbH. His work in these companies has allowed him to further refine his expertise in the fields of biomedicine and intellectual property related to healthcare innovations.
Collaborations
Satozawa has collaborated with renowned colleagues such as Tara Renee Heitner Hansen and David Richard Light. These partnerships have contributed to the development of his innovative patents and have fostered an environment of shared knowledge and expertise in the pursuit of advancing cancer treatment solutions.
Conclusion
Noboru Satozawa's contributions to the medical field through his innovative inventions demonstrate his commitment to improving cancer diagnostics and therapeutics. With his groundbreaking patents, he continues to pave the way for future advancements in oncology, underscoring the importance of innovation in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile